BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29843210)

  • 1. Study on the methylation status of SPINT2 gene and its expression in cervical carcinoma.
    Wang N; Che Y; Yin F; Yu F; Bi X; Wang Y
    Cancer Biomark; 2018; 22(3):435-442. PubMed ID: 29843210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPINT2 Deregulation in Prostate Carcinoma.
    Pereira MS; de Almeida GC; Pinto F; Viana-Pereira M; Reis RM
    J Histochem Cytochem; 2016 Jan; 64(1):32-41. PubMed ID: 26442953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.
    Fukushima T; Kawaguchi M; Yamamoto K; Yamashita F; Izumi A; Kaieda T; Takezaki Y; Itoh H; Takeshima H; Kataoka H
    Cancer Sci; 2018 Sep; 109(9):2970-2979. PubMed ID: 29987920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer.
    Dong W; Chen X; Xie J; Sun P; Wu Y
    Int J Cancer; 2010 Oct; 127(7):1526-34. PubMed ID: 20063316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.
    Oikonomou P; Messinis I; Tsezou A
    Exp Biol Med (Maywood); 2007 Jul; 232(7):881-6. PubMed ID: 17609503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.
    Liu F; Cox CD; Chowdhury R; Dovek L; Nguyen H; Li T; Li S; Ozer B; Chou A; Nguyen N; Wei B; Antonios J; Soto H; Kornblum H; Liau L; Prins R; Nghiemphu PL; Yong W; Cloughesy T; Lai A
    J Neurooncol; 2019 May; 142(3):423-434. PubMed ID: 30838489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
    Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between Methylation of SALL3 and Cervical Cancer].
    Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
    Ye F; Zhang SF; Xie X; Lu WG
    Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
    Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.
    Hwang S; Kim HE; Min M; Raghunathan R; Panova IP; Munshi R; Ryu B
    J Invest Dermatol; 2015 Sep; 135(9):2283-2291. PubMed ID: 25910030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter Methylation and Relative mRNA Expression of the p16 Gene in Cervical Cancer in North Indians.
    Gupta A; Ahmad MK; Mahndi AA; Singh R; Pradeep Y
    Asian Pac J Cancer Prev; 2016; 17(8):4149-54. PubMed ID: 27644676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.
    Pereira MS; Celeiro SP; Costa ÂM; Pinto F; Popov S; de Almeida GC; Amorim J; Pires MM; Pinheiro C; Lopes JM; Honavar M; Costa P; Pimentel J; Jones C; Reis RM; Viana-Pereira M
    Cell Oncol (Dordr); 2020 Feb; 43(1):107-121. PubMed ID: 31701492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.